Alan L Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
2
2
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Marco Raffaelli, Prof
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Shared therapeutic areas:
Joanna Klubo-Gwiezdzinska, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
CHIH-YUAN WANG, Doctor
Department of Internal Medicine, National Taiwan University Hospital
Shared therapeutic areas:
Kong Y Chen, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Matthew Krebs, Dr
The Christie Hospital
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Wendy Demark-Wahnefried, PhD, RD
University of Alabama at Birmingham
Shared therapeutic areas:
Lin Liao, MD
Qianfoshan Hospital
Shared therapeutic areas:
Alan Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Marie-France Langlois, MD
Université de Sherbrooke
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
All 2 trials loaded